CTNM Contineum Therapeutics, Inc.
Fundamentals / CIK 0001855175 / USDContineum Therapeutics, Inc. reported $257.0M in total assets and a net loss of $63.46M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CTNM in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$72.41M Operating profit
-
Net Income FY 2025-$63.46M GAAP bottom line
-
Diluted EPS FY 2025-$1.65 Split-adjusted
-
Free Cash Flow FY 2025-$52.23M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$244.5M Total debt: $6.27M
Annual revenue and net income
3 fiscal years (2023 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Revenue | -- | $0 | $50.00M |
| Research & Development | $51.52M | $38.42M | $27.60M |
| Total Operating Expenses | $68.06M | $50.89M | $33.92M |
| Operating Income | -$68.06M | -$50.89M | $16.08M |
| EBITDA | -$67.74M | -$50.64M | $16.27M |
| Interest Income | $8.25M | $8.90M | $4.61M |
| Interest Expense | -- | $0 | $208K |
| Income Before Tax | -$60.14M | -$42.26M | $23.17M |
| Income Tax Expense | $0 | $0 | $450K |
| Net Income | -$59.98M | -$42.26M | $22.72M |
| Basic EPS | -$2.17 | -$2.18 | $1.36 |
| Diluted EPS | -$2.17 | -$2.18 | $0.08 |
| Basic Shares Outstanding | 27.7M | 19.4M | 2.3M |
| Diluted Shares Outstanding | 27.7M | 19.4M | 3.4M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $15.98M | $12.70M | $11.65M | $12.76M | $10.99M | $14.06M | $13.71M | $13.02M |
| Total Operating Expenses | $20.97M | $17.43M | $16.90M | $17.11M | $14.93M | $17.90M | $18.11M | $17.05M |
| Operating Income | -$20.97M | -$17.43M | -$16.90M | -$17.11M | -$14.93M | -$17.90M | -$18.11M | -$17.05M |
| EBITDA | -$20.89M | -$17.29M | -$16.82M | -$17.03M | -$14.85M | -$17.82M | -$18.03M | -$16.97M |
| Interest Income | $2.36M | $2.34M | $2.50M | $2.01M | $1.96M | $2.03M | $2.25M | $2.53M |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | $0 |
| Income Before Tax | -- | -- | -- | -- | -- | -- | -- | -$14.56M |
| Income Tax Expense | -- | -- | -- | -- | -- | -- | -- | $0 |
| Net Income | -$18.70M | -$15.15M | -$14.46M | -$15.16M | -$12.79M | -$16.04M | -$15.99M | -$14.56M |
| Basic EPS | -$0.49 | -$0.40 | -$0.39 | -- | -$0.45 | -$0.62 | -$0.62 | -- |
| Diluted EPS | -$0.49 | -$0.40 | -$0.39 | -- | -$0.45 | -$0.62 | -$0.62 | -- |
| Basic Shares Outstanding | 38.4M | 37.5M | 37.3M | -- | 28.1M | 25.9M | 25.9M | -- |
| Diluted Shares Outstanding | 38.4M | 37.5M | 37.3M | -- | 28.1M | 25.9M | 25.9M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Cash & Cash Equivalents | $75.60M | $21.94M | $15.53M |
| Short-Term Investments | $187.3M | $182.8M | $109.7M |
| Cash & Short-Term Investments | $262.9M | $204.8M | $125.2M |
| Total Current Assets | $267.9M | $206.4M | $127.7M |
| Property, Plant & Equipment, Net | $830K | $989K | $678K |
| Other Non-Current Assets | $256K | $3.0K | $1.28M |
| Total Non-Current Assets | $8.72M | $6.46M | $2.68M |
| Total Assets | $276.6M | $212.8M | $130.4M |
| Accounts Payable | $1.02M | $1.81M | $635K |
| Total Current Liabilities | $9.74M | $9.97M | $5.48M |
| Other Non-Current Liabilities | -- | $0 | $110K |
| Total Non-Current Liabilities | $5.91M | $4.81M | $218K |
| Total Liabilities | $15.65M | $14.78M | $5.70M |
| Total Debt (incl. Leases) | $8.25M | $6.26M | $572K |
| Common Stock | -- | -- | $2.0K |
| Retained Earnings | -$177.4M | -$117.4M | -$75.14M |
| Accumulated Other Comp. Income | $260K | $71K | $108K |
| Total Stockholders' Equity | $261.0M | $198.1M | -$67.94M |
| Total Equity | $261.0M | $198.1M | -$67.94M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $75.20M | $14.71M | $20.16M | $75.60M | $42.63M | $20.78M | $22.47M | $21.94M |
| Short-Term Investments | $169.3M | $221.8M | $226.2M | $187.3M | $139.8M | $154.7M | $168.2M | $182.8M |
| Cash & Short-Term Investments | $244.5M | $236.6M | $246.3M | $262.9M | $182.4M | $175.5M | $190.7M | $204.8M |
| Total Current Assets | $249.7M | $242.6M | $253.0M | $267.9M | $184.9M | $176.8M | $192.1M | $206.4M |
| Property, Plant & Equipment, Net | $848K | $929K | $1.06M | $830K | $880K | $856K | $891K | $989K |
| Other Non-Current Assets | $300K | $364K | $312K | $256K | $266K | $186K | $4.0K | $3.0K |
| Total Non-Current Assets | $7.24M | $7.79M | $8.38M | $8.72M | $5.92M | $6.05M | $6.13M | $6.46M |
| Total Assets | $257.0M | $250.4M | $261.3M | $276.6M | $190.8M | $182.9M | $198.3M | $212.8M |
| Accounts Payable | $641K | $505K | $1.50M | $1.02M | $786K | $2.00M | $3.65M | $1.81M |
| Total Current Liabilities | $8.03M | $6.53M | $6.66M | $9.74M | $6.36M | $7.21M | $8.95M | $9.97M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $0 |
| Total Non-Current Liabilities | $3.54M | $4.18M | $4.65M | $5.91M | $4.02M | $4.28M | $4.55M | $4.81M |
| Total Liabilities | $11.57M | $10.71M | $11.31M | $15.65M | $10.38M | $11.50M | $13.50M | $14.78M |
| Total Debt (incl. Leases) | $6.27M | $6.57M | $6.95M | $8.25M | $5.49M | $5.75M | $6.00M | $6.26M |
| Retained Earnings | -$225.7M | -$207.0M | -$191.8M | -$177.4M | -$162.2M | -$149.4M | -$133.4M | -$117.4M |
| Accumulated Other Comp. Income | -$1.51M | -$573K | -$253K | $260K | $265K | $147K | $170K | $71K |
| Total Stockholders' Equity | $245.4M | $239.7M | $250.0M | $261.0M | $180.5M | $171.4M | $184.8M | $198.1M |
| Total Equity | $245.4M | $239.7M | $250.0M | $261.0M | $180.5M | $171.4M | $184.8M | $198.1M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Net Income | -$59.98M | -$42.26M | $22.72M |
| Depreciation & Amortization | $323K | $258K | $195K |
| Stock-Based Compensation | $10.04M | $6.80M | $2.22M |
| Change in Payables | -$869K | $1.14M | $0 |
| Operating Cash Flow | -$55.31M | -$32.84M | $19.35M |
| Capital Expenditure | -$231K | -$514K | -$414K |
| Free Cash Flow | -$55.54M | -$33.36M | $18.93M |
| Purchases of Investments | -$162.5M | -$226.4M | -$141.9M |
| Investing Cash Flow | -$3.71M | -$69.74M | -$65.57M |
| Common Stock Issued | -- | $108.2M | $0 |
| Share Repurchases | -- | $0 | -$28K |
| Financing Cash Flow | $112.7M | $109.0M | $56.18M |
| Net Change in Cash | $53.66M | $6.42M | $9.96M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$18.70M | -$15.15M | -$14.46M | -$15.16M | -$12.79M | -$16.04M | -$15.99M | -$14.56M |
| Depreciation & Amortization | $81K | $134K | $83K | $85K | $81K | $79K | $78K | $75K |
| Stock-Based Compensation | $4.86M | $3.84M | $3.82M | $2.48M | $2.57M | $2.42M | $2.57M | $2.25M |
| Change in Payables | $136K | -$990K | $490K | $162K | -$1.22M | -$1.64M | $1.83M | $378K |
| Operating Cash Flow | -$11.06M | -$11.50M | -$16.27M | -$13.04M | -$12.20M | -$15.66M | -$14.41M | -$10.20M |
| Capital Expenditure | $0 | -$6.0K | -$312K | -$42K | -$98K | -$44K | -$47K | -$166K |
| Free Cash Flow | -$11.06M | -$11.51M | -$16.58M | -$13.08M | -$12.29M | -$15.71M | -$14.46M | -$10.37M |
| Purchases of Investments | -$16.04M | -$45.78M | -$97.12M | -$84.73M | -$18.64M | -$25.44M | -$33.69M | -$54.35M |
| Investing Cash Flow | $50.95M | $4.85M | -$39.31M | -$47.45M | $14.94M | $13.88M | $14.91M | -$9.39M |
| Financing Cash Flow | $20.59M | $1.20M | $129K | $93.47M | $19.11M | $91K | $24K | $642K |
| Net Change in Cash | $60.49M | -$5.45M | -$55.45M | $32.97M | $21.85M | -$1.69M | $527K | -$18.95M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Operating Margin | -- | -- | 32.2% |
| Net Profit Margin | -- | -- | 45.4% |
| Return on Equity (ROE) | -23.0% | -21.3% | -- |
| Return on Assets (ROA) | -21.7% | -19.9% | 17.4% |
| Current Ratio | 27.50x | 20.69x | 23.29x |
| Quick Ratio | 26.98x | 20.53x | 22.83x |
| Debt to Equity | 0.03x | 0.03x | -- |
| Revenue Growth (YoY) | -- | -100.0% | -- |
| Operating Income Growth (YoY) | -- | -416.6% | -- |
| Net Income Growth (YoY) | -- | -286.0% | -- |
| EPS Growth (YoY) | -- | -260.3% | -- |
| Operating Cash Flow Growth (YoY) | -- | -269.8% | -- |
| Free Cash Flow Growth (YoY) | -- | -276.2% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -25.9% | -24.0% | -23.4% | -23.0% | -32.9% | -33.2% | -27.0% | -21.3% |
| Return on Assets (ROA) | -24.7% | -23.0% | -22.4% | -21.7% | -31.1% | -31.1% | -25.1% | -19.9% |
| Current Ratio | 31.11x | 37.17x | 38.00x | 27.50x | 29.07x | 24.51x | 21.47x | 20.69x |
| Quick Ratio | 30.46x | 36.25x | 37.00x | 26.98x | 28.67x | 24.33x | 21.31x | 20.53x |
| Debt to Equity | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x |